Hormonal
GLP-1 receptor agonist therapy causes a significant increase in resting heart rate (RHR) during the initial 12 weeks of treatment, which is primarily mediated by a reduction in heart rate variability (HRV).
If you start a GLP-1 medication (like semaglutide or tirzepatide), expect your resting heart rate to increase by about 3 beats per minute over the first 3 months. This is a normal, mediated response involving your autonomic nervous system (HRV), not necessarily a sign of heart damage. If you use a wearable, track this trend, but consult your doctor if the increase is extreme or accompanied by other symptoms.
GLP-1 users showed significant (Ps < 0.05) weight loss... and changes in RHR (3.2 ± 0.8 beats/min) that were mediated (P < 0.01) by changes in HRV ((cid:1)6.2 ± 1.4 ms) compared with control.
Why this rating
Real-world observational study with propensity score matching and causal inference, but lacks randomization and specific drug/dose details.
Source
Heart and health behavior responses to GLP-1 receptor agonists: a 12-wk study using wearable technology and causal inference
Gregory J. Grosicki et al. · American Journal of Physiology-Heart and Circulatory Physiology · 2024
DOI 10.1152/ajpheart.00809.2024
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →